Literature DB >> 18688563

MiRNAs, epigenetics, and cancer.

Arefeh Rouhi1, Dixie L Mager, R Keith Humphries, Florian Kuchenbauer.   

Abstract

By virtue of having multiple targets, a microRNA (miRNA) can have variable effects on oncogenesis by acting as tumor suppressor or oncogene in a context-dependent manner. Genome-wide epigenetic changes that occur in various cancers affect the transcription of many genes. Since the transcriptional regulation of miRNAs remains an unexplored field, it is still unknown how epigenetic changes will affect the regulation of miRNAs. Many miRNAs are intron-bound within the body of a protein-coding gene. Any change to the transcription of the "host" gene affects the transcription and genesis of the resident miRNA. It is therefore reasonable to deduce that epigenetic changes brought on by transformation can potentially affect miRNA expression in both direct and indirect ways. We have reviewed the literature pertaining to the epigenetic regulation of miRNA genes in the context of various cancers and have speculated on the potential role of epigenetic modifications on the transcriptional regulation and expression of these genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688563     DOI: 10.1007/s00335-008-9133-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  95 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 2.  The nucleosome: from genomic organization to genomic regulation.

Authors:  Sepideh Khorasanizadeh
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Transposons reanimated in mice.

Authors:  Timothy H Bestor
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

4.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

Review 5.  Camels and zebrafish, viruses and cancer: a microRNA update.

Authors:  Eugene Berezikov; Ronald H A Plasterk
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

6.  HDAC4 deacetylase associates with and represses the MEF2 transcription factor.

Authors:  E A Miska; C Karlsson; E Langley; S J Nielsen; J Pines; T Kouzarides
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

Review 7.  Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

Authors:  A W Tong; J Nemunaitis
Journal:  Cancer Gene Ther       Date:  2008-03-28       Impact factor: 5.987

8.  Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.

Authors:  U Lehmann; B Hasemeier; M Christgen; M Müller; D Römermann; F Länger; H Kreipe
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  26 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 2.  Epigenetics and cancer.

Authors:  Rajnee Kanwal; Sanjay Gupta
Journal:  J Appl Physiol (1985)       Date:  2010-03-04

3.  Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.

Authors:  Song Liu
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

4.  MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.

Authors:  D-J Min; T Ezponda; M K Kim; C M Will; E Martinez-Garcia; R Popovic; V Basrur; K S Elenitoba-Johnson; J D Licht
Journal:  Leukemia       Date:  2012-09-13       Impact factor: 11.528

Review 5.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

Authors:  Alexander Link; Francesc Balaguer; Ajay Goel
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 5.858

6.  Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.

Authors:  Sally L Rogers; Yun Zhao; Xiaoyan Jiang; Connie J Eaves; Dixie L Mager; Arefeh Rouhi
Journal:  Mol Cancer       Date:  2010-02-22       Impact factor: 27.401

7.  The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.

Authors:  Liselle C Bovell; Chandrakumar Shanmugam; Balananda-Dhurjati K Putcha; Venkat R Katkoori; Bin Zhang; Sejong Bae; Karan P Singh; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

Review 8.  Epigenetic changes in carcinogenesis of gallbladder.

Authors:  Mallika Tewari; Amit Agarwal; R R Mishra; R N Meena; Hari S Shukla
Journal:  Indian J Surg Oncol       Date:  2013-04-04

9.  Epigenetics in gastrointestinal stromal tumors: clinical implications and potential therapeutic perspectives.

Authors:  Athanasios D Sioulas; Diamantina Vasilatou; Vasiliki Pappa; George Dimitriadis; Konstantinos Triantafyllou
Journal:  Dig Dis Sci       Date:  2013-07-20       Impact factor: 3.199

10.  The noncoding RNAs: a genomic symphony of transcripts.

Authors:  Linda D Siracusa; Arthur M Buchberg
Journal:  Mamm Genome       Date:  2008-11-15       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.